Bhagiradha Chemicals reported FY26 consolidated revenue of ₹535.9 Cr, up 22% YoY, driven by volume growth and improved realizations.
FY26 EBITDA surged 55% to ₹57.1 Cr with margins expanding to 10.7%, supported by operational efficiency and lower power costs from solar project.
The company commissioned Phase I of its Bheema Fine Chemicals facility, capitalizing ~₹400 Cr, and launched 3 new molecules with 19 new customers.
Board recommended a final dividend of ₹0.15 per share for FY26, subject to shareholder approval.